Definition
This research blend pairs CJC-1295 without Drug Affinity Complex (often discussed with Modified GRF 1-29) and Ipamorelin (CAS 170851-70-4). The no-DAC form is distinct from long-acting DAC-containing CJC constructs.
Key Facts
- Blend: CJC-1295 (no DAC) + Ipamorelin
- CAS: ~863288-34-0; 170851-70-4
- Size: 5 mg
- Purity: ≥99% HPLC; batch COA
- Use: Laboratory research only
Last reviewed: 2026-10-15
Key Characteristics
MOLECULAR PROFILE
Blend: CJC-1295 no DAC + Ipamorelin
CJC no DAC CAS: ~863288-34-0
Ipamorelin CAS: 170851-70-4
PHYSICAL PROPERTIES
Form: White to off-white lyophilized powder
Solubility: Soluble in bacteriostatic water or sterile lab-grade water
Stability: Stable when stored dry, cold, and protected from light
Storage: -20°C preferred (lyophilized); 2-8°C after reconstitution
Mechanism of Action (Research Context)
CJC-1295 without DAC is studied as a GHRH-analog tool with a shorter activity window than DAC forms. Ipamorelin is studied as a selective ghrelin (GHS-R1a) receptor agonist peptide. Combined vials support dual-pathway research designs. Not medicines.
Research Applications
- GHRH-analog and ghrelin-receptor co-stimulation designs
- No-DAC versus DAC literature comparison on the bench
- Two-peptide blend analytical work
Laboratory Notes
High-level handling notes for CJC-1295 + Ipamorelin. Detailed reconstitution steps live on the product page. Always defer to your lab SOP and batch COA.
Scientific References
- Ipamorelin pharmacology literature (CAS 170851-70-4).
- Modified GRF 1-29 / CJC-1295 without DAC literature. Confirm COA.
Buy Research-Grade Material
Buy research-grade CJC-1295 + Ipamorelin from Osae Research (sizes, COA, shipping).
Legal Disclaimer
Content is for scientific orientation. Materials from Osae Research are for laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.